Cargando…
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
Background: Alzheimer Disease (AD) is the most prevalent dementia. However, the physiopathological mechanisms involved in its development are unclear. In this sense, a multi-omics approach could provide some progress. Methods: Epigenomic and lipidomic analysis were carried out in plasma samples from...
Autores principales: | Peña-Bautista, Carmen, Álvarez-Sánchez, Lourdes, Cañada-Martínez, Antonio José, Baquero, Miguel, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698767/ https://www.ncbi.nlm.nih.gov/pubmed/34944628 http://dx.doi.org/10.3390/biomedicines9121812 |
Ejemplares similares
-
Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022) -
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
por: Mayo, Sonia, et al.
Publicado: (2021) -
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023) -
Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
por: García-Vallés, Lorena, et al.
Publicado: (2022) -
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
por: Ferré-González, Laura, et al.
Publicado: (2021)